Is immunotherapy in the future of therapeutic management of sarcomas?

被引：24

作者：

Clemente, Ottavia ^{[1
]}

Ottaiano, Alessandro ^{[2
]}

Di Lorenzo, Giuseppe ^{[1
]}

Bracigliano, Alessandra ^{[3
]}

Lamia, Sabrina ^{[1
]}

Cannella, Lucia ^{[1
]}

Pizzolorusso, Antonio ^{[1
]}

Di Marzo, Massimiliano ^{[4
]}

Santorsola, Mariachiara ^{[2
]}

De Chiara, Annarosaria ^{[5
]}

Fazioli, Flavio ^{[6
]}

Tafuto, Salvatore ^{[1
]}

机构：

[1] IRCCS Fdn G Pascale, Sarcomas & Rare Tumors Unit, Ist Nazl Tumori, I-80131 Naples, Italy

[2] IRCCS Fdn G Pascale, Div Innovat Therapies, Ist Nazl Tumori, I-80131 Naples, Italy

[3] IRCCS Fdn G Pascale, Nucl Med Unit, Ist Nazl Tumori, I-80131 Naples, Italy

[4] IRCCS Fdn G Pascale, Dept Abdominal Oncol, Ist Nazl Tumori, I-80131 Naples, Italy

[5] IRCCS Fdn G Pascale, Ist Nazl Tumori, Histopathol Lymphomas & Sarcomas SSD, I-80131 Naples, Italy

[6] IRCCS Fdn G Pascale, Orthoped Oncol Unit, Ist Nazl Tumori, I-80131 Naples, Italy

来源：

JOURNAL OF TRANSLATIONAL MEDICINE | 2021年 / 19卷 / 01期

关键词：

Soft tissue sarcoma; Osteosarcoma; Immunotherapy; Anti-cancer vaccine; CAR-T therapy; SOFT-TISSUE SARCOMA; TUMOR-INFILTRATING LYMPHOCYTES; T-CELL-RECEPTOR; TARGETED ONCOLYTIC POXVIRUS; HUMORAL IMMUNE-RESPONSE; CANCER-TESTIS ANTIGEN; PHASE-I TRIAL; SYNOVIAL SARCOMA; BONE SARCOMA; OPEN-LABEL;

D O I：

10.1186/s12967-021-02829-y

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Sarcomas are rare, ubiquitous and heterogeneous tumors usually treated with surgery, chemotherapy, target therapy, and radiotherapy. However, 25-50% of patients experience local relapses and/or distant metastases after chemotherapy with an overall survival about 12-18 months. Recently, immuno-therapy has revolutionized the cancer treatments with initial indications for non-small cell lung cancer (NSCLC) and melanoma (immune-checkpoint inhibitors).Here, we provide a narrative review on the topic as well as a critical description of the currently available trials on immunotherapy treatments in patients with sarcoma. Given the promising results obtained with anti-PD-1 monoclonal antibodies (pembrolizumab and nivolumab) and CAR-T cells, we strongly believe that these new immunotherapeutic approaches, along with an innovative characterization of tumor genetics, will provide an exciting opportunity to ameliorate the therapeutic management of sarcomas.

引用

页数：24

共 155 条

[71] Cancer immunoediting from immune surveillance to immune escape [J].

Kim, Ryungsa ;

Emi, Manabu ;

Tanabe, Kazuaki .

IMMUNOLOGY, 2007, 121 (01) :1-14

[72] Well-differentiated inflammatory liposarcoma: An uncommon and easily overlooked variant of a common sarcoma [J].

Kraus, MD ;

Guillou, L ;

Fletcher, CDM .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1997, 21 (05) :518-527

[73] A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma [J].

Krishnadas, Deepa K. ;

Shusterman, Suzanne ;

Bai, Fanqi ;

Diller, Lisa ;

Sullivan, Janice E. ;

Cheerva, Alexandra C. ;

George, Rani E. ;

Lucas, Kenneth G. .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (10) :1251-1260

[74] Dedifferentiated liposarcoma with extensive lymphoid component [J].

Kuhnen, C ;

Mentzel, T ;

Sciot, R ;

Lehnhardt, M ;

Homann, HH ;

Debiec-Rychter, M .

PATHOLOGY RESEARCH AND PRACTICE, 2005, 201 (04) :347-353

[75] PD-1/PD-L1 in disease [J].

Kuol, Nyanbol ;

Stojanovska, Lily ;

Nurgali, Kulmira ;

Apostolopoulos, Vasso .

IMMUNOTHERAPY, 2018, 10 (02) :149-161

[76] NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis [J].

Lai, Jin-Ping ;

Robbins, Paul F. ;

Raffeld, Mark ;

Aung, Phyu Phyu ;

Tsokos, Maria ;

Rosenberg, Steven A. ;

Miettinen, Markku M. ;

Lee, Chyi-Chia Richard .

MODERN PATHOLOGY, 2012, 25 (06) :854-858

[77] Oncolytic Maraba Virus MG1 as a Treatment for Sarcoma [J].

Le Boeuf, Fabrice ;

Selman, Mohammed ;

Son, Hwan Hee ;

Bergeron, Anabel ;

Chen, Andrew ;

Tsang, Jovian ;

Butterwick, Derek ;

Arulanandam, Rozanne ;

Forbes, Nicole E. ;

Tzelepis, Fanny ;

Bell, John C. ;

Werier, Joel ;

Abdelbary, Hesham ;

Diallo, Jean-Simon .

INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (06) :1257-1264

[78] PD-1 Blockade in Tumors with Mismatch-Repair Deficiency [J].

Le, D. T. ;

Uram, J. N. ;

Wang, H. ;

Bartlett, B. R. ;

Kemberling, H. ;

Eyring, A. D. ;

Skora, A. D. ;

Luber, B. S. ;

Azad, N. S. ;

Laheru, D. ;

Biedrzycki, B. ;

Donehower, R. C. ;

Zaheer, A. ;

Fisher, G. A. ;

Crocenzi, T. S. ;

Lee, J. J. ;

Duffy, S. M. ;

Goldberg, R. M. ;

de la Chapelle, A. ;

Koshiji, M. ;

Bhaijee, F. ;

Huebner, T. ;

Hruban, R. H. ;

Wood, L. D. ;

Cuka, N. ;

Pardoll, D. M. ;

Papadopoulos, N. ;

Kinzler, K. W. ;

Zhou, S. ;

Cornish, T. C. ;

Taube, J. M. ;

Anders, R. A. ;

Eshleman, J. R. ;

Vogelstein, B. ;

Diaz, L. A., Jr. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (26) :2509-2520

[79] Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade [J].

Le, Dung T. ;

Durham, Jennifer N. ;

Smith, Kellie N. ;

Wang, Hao ;

Bartlett, Bjarne R. ;

Aulakh, Laveet K. ;

Lu, Steve ;

Kemberling, Holly ;

Wilt, Cara ;

Luber, Brandon S. ;

Wong, Fay ;

Azad, Nilofer S. ;

Rucki, Agnieszka A. ;

Laheru, Dan ;

Donehower, Ross ;

Zaheer, Atif ;

Fisher, George A. ;

Crocenzi, Todd S. ;

Lee, James J. ;

Greten, Tim F. ;

Duffy, Austin G. ;

Ciombor, Kristen K. ;

Eyring, Aleksandra D. ;

Lam, Bao H. ;

Joe, Andrew ;

Kang, S. Peter ;

Holdhoff, Matthias ;

Danilova, Ludmila ;

Cope, Leslie ;

Meyer, Christian ;

Zhou, Shibin ;

Goldberg, Richard M. ;

Armstrong, Deborah K. ;

Bever, Katherine M. ;

Fader, Amanda N. ;

Taube, Janis ;

Housseau, Franck ;

Spetzler, David ;

Xiao, Nianqing ;

Pardoll, Drew M. ;

Papadopoulos, Nickolas ;

Kinzler, Kenneth W. ;

Eshleman, James R. ;

Vogelstein, Bert ;

Anders, Robert A. ;

Diaz, Luis A., Jr. .

SCIENCE, 2017, 357 (6349) :409-413

[80] First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication [J].

Lemery, Steven ;

Keegan, Patricia ;

Pazdur, Richard .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (15) :1409-1412

← 3 4 5 6 7 8 9 10 11 12 →